PF-3732010 | m-entrepreneurship.com

Product Name :
PF-3732010

Search keywords :
PF-03732010

drugId :
null

Target Vo:
Cadherin 3

Target Vo Short Name :
CDH3

Moa_Name:
Cadherin 3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-ERK1/2 (Thr202/Thr185) Antibody
BRAF Antibody
CEA Antibody (YA916): CEA Antibody (YA916) is an unconjugated, approximately 150-200 kDa, mouse-derived, anti-CEA (YA916) monoclonal antibody. CEA Antibody (YA916) can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.

Author: Betaine hydrochloride

Related Posts